The 2010 European Society of Cardiology Guidelines on the management of atrial fibrillation: an evolution or revolution?

Chest. 2011 Apr;139(4):738-741. doi: 10.1378/chest.10-2763.

Authors

Gregory Y H Lip¹, Jonathan L Halperin², Hung-Fat Tse³

Affiliations

¹ University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, England. Electronic address: g.y.h.lip@bham.ac.uk.
² The Cardiovascular Institute, Mount Sinai Medical Center, New York, NY.
³ Cardiology Division, Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, PRC.

PMID: 21467053
DOI: 10.1378/chest.10-2763

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Aged
Anti-Arrhythmia Agents / therapeutic use*
Atrial Fibrillation / complications
Atrial Fibrillation / epidemiology
Atrial Fibrillation / therapy*
Cardiology*
Catheter Ablation / methods*
Europe
Female
Fibrinolytic Agents / therapeutic use
Humans
Incidence
Male
Practice Guidelines as Topic*
Prevalence
Risk Factors
Societies, Medical*
Stroke / epidemiology
Stroke / etiology
Stroke / prevention & control*

Substances

Anti-Arrhythmia Agents
Fibrinolytic Agents